|
| |
BioPortfolio's Approved Drugs DatabaseLacrisertHydroxypropyl CelluloseDownload PDF containing detailed information.
Press Releases About Lacrisert:
|
 |
| Aton Pharma CEO Mike Wells Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winner; |
30th June, 2009 |
Aton Pharma, Inc. |
Award Recognizes Entrepreneurial Excellence
LAWRENCEVILLE, N.J., June 30 /PRNewswire/ -- Aton Pharma, Inc. announced today that its Chief Executive Officer, Michael G. Wells, has received the Ernst
|
| ARVO, AOS: Large Study of Lacrisert(R) Dry Eye Insert; |
4th May, 2009 |
Aton Pharma, Inc. |
Patients Experience Significant Improvement in Ocular Surface Disease and Quality of Life
LAWRENCEVILLE, N.J., May 4 /PRNewswire/ -- Aton Pharma, Inc. announced today that results from a large (n =
|
| Dry Eye Survey: Ophthalmologists Cite Treatment Limitations/Gaps in Treatment of Moderate to Severe Dry Eye |
10th November, 2008 |
Aton Pharma, Inc. |
LAWRENCEVILLE, N.J., Nov. 10 /PRNewswire/ -- Aton Pharma, Inc., a
diversified specialty pharmaceutical company, announced results of a recent
survey of ophthalmologists regarding issues in the
|
This page has been viewed 20 times Recent Search Terms used to find this page: .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Lacrisert across BioPortfolio, or for Lacrisert Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|